Goldstone Financial Group LLC Buys New Shares in Senseonics Holdings, Inc. $SENS

Goldstone Financial Group LLC purchased a new position in Senseonics Holdings, Inc. (NYSE:SENS) during the third quarter, HoldingsChannel reports. The institutional investor purchased 120,000 shares of the company’s stock, valued at approximately $52,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. First Light Asset Management LLC lifted its holdings in shares of Senseonics by 666.7% during the 2nd quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock worth $17,011,000 after acquiring an additional 31,050,619 shares during the period. Geode Capital Management LLC increased its position in Senseonics by 26.6% during the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock worth $4,147,000 after purchasing an additional 1,828,302 shares during the last quarter. Hood River Capital Management LLC acquired a new position in Senseonics during the second quarter worth approximately $3,775,000. Sio Capital Management LLC purchased a new position in Senseonics during the second quarter worth approximately $2,312,000. Finally, Sei Investments Co. acquired a new position in shares of Senseonics in the 2nd quarter valued at $761,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

Analyst Upgrades and Downgrades

SENS has been the subject of a number of research analyst reports. TD Cowen dropped their price objective on Senseonics from $25.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Stifel Nicolaus initiated coverage on Senseonics in a research report on Tuesday, October 21st. They set a “hold” rating and a $9.00 price target for the company. HC Wainwright upped their price target on Senseonics to $18.50 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Finally, Barclays reaffirmed an “overweight” rating and issued a $31.00 price objective (up from $1.50) on shares of Senseonics in a research note on Wednesday, November 5th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $22.70.

Insider Activity

In related news, Director Edelman Steven purchased 10,000 shares of the firm’s stock in a transaction on Monday, November 10th. The stock was purchased at an average price of $6.55 per share, for a total transaction of $65,500.00. Following the acquisition, the director directly owned 74,708 shares in the company, valued at $489,337.40. The trade was a 15.45% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Frederick T. Sullivan acquired 5,415 shares of the company’s stock in a transaction dated Friday, November 7th. The shares were purchased at an average price of $5.88 per share, for a total transaction of $31,840.20. Following the purchase, the chief financial officer directly owned 157,028 shares of the company’s stock, valued at approximately $923,324.64. This trade represents a 3.57% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders purchased 30,415 shares of company stock worth $184,790. 3.60% of the stock is currently owned by corporate insiders.

Senseonics Stock Down 5.8%

Shares of NYSE SENS opened at $5.67 on Tuesday. The stock has a fifty day moving average price of $6.44 and a 200 day moving average price of $8.48. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. Senseonics Holdings, Inc. has a 12-month low of $5.25 and a 12-month high of $28.00. The company has a market cap of $231.67 million, a P/E ratio of -43.62 and a beta of 0.92.

About Senseonics

Senseonics Holdings, Inc is a medical technology company focused on the development and commercialization of innovative continuous glucose monitoring (CGM) systems for people with diabetes. Since its founding in 2011 and headquartered in Germantown, Maryland, the company has pioneered an implantable sensor designed to deliver long-term glucose readings. Senseonics’ mission centers on improving diabetes management by providing accurate, real-time data to patients and healthcare providers.

The company’s flagship offering is the Eversense CGM System, which features a small, fully implantable sensor placed beneath the skin to measure glucose levels for up to 90 days in the United States and up to 180 days in Europe.